SHBG and polycystic ovary syndrome: TZDs can alleviate HA by upregulating the expression of liver sex hormone-binding globulin (SHBG), directly regulate ovarian function through a variety of mechanisms [15, 16], and play a role in preventing the metabolic consequences in PCOS women [17–20].